Home Microsoft CVE-2026-32172
Back to Microsoft

CVE-2026-32172

Microsoft Power Apps

Microsoft CVSS 8 Updated April 30, 2026

Executive Risk Summary

"An uncontrolled search path element vulnerability in Microsoft Power Apps allows an unauthorized attacker to execute code over a network, potentially leading to code execution and system compromise. This vulnerability can be exploited by an attacker without authentication, making it a high-risk issue."

Anticipated Attack Path

  1. 1. Initial Exploitation: Attacker discovers and exploits the uncontrolled search path element vulnerability
  2. 2. Privilege Escalation: Attacker gains elevated privileges on the Microsoft Power Apps server
  3. 3. Lateral Movement: Attacker moves laterally within the network, exploiting other vulnerable systems

Am I Vulnerable?

  • Verify Microsoft Power Apps version and patch level
  • Check for any suspicious activity or code execution on the server
  • Review system logs for signs of exploitation or unauthorized access

Operational Audit Arsenal

Target Type Service
Target Asset Microsoft.PowerApps.exe
Standard Path C:\Program Files\Microsoft Power Apps\
PowerShell
# 🛠️ Senior Engineer Universal Audit
# Target: Microsoft.PowerApps.exe (Service)
$Targets = 'Microsoft.PowerApps.exe'
$SearchPaths = @("$env:windir\System32", "$env:ProgramFiles", "${env:ProgramFiles(x86)}")

Get-ChildItem -Path $SearchPaths -Include $Targets -Recurse -ErrorAction SilentlyContinue | 
Select-Object FullName, @{Name="Version";Expression={$_.VersionInfo.ProductVersion}}

Patch Impact Forecast

Reboot Required Likely

Potential disruption to Microsoft Power Apps services and dependent applications

Internal Work Notes

High-risk vulnerability in Microsoft Power Apps requires immediate patching and verification to prevent code execution and system compromise.

Technical Intelligence & Operational Utilities • Delivered Weekly

Intelligence Sources

Related Microsoft Threats

Data compiled from NVD, MSRC, and CISA KEV Catalog. Intelligence synthesized via AI. Scripts provided for diagnostic purposes under MIT License.